Rosiglitazone-loaded Nanospheres for Modulating Macrophage-Specific Inflammation in obesity

PPARγ nuclear receptor agonists have been shown to attenuate macrophage inflammatory responses implicated in the metabolic complications of obesity and in atherosclerosis. However, PPARγ agonists currently in clinical use, including rosiglitazone (RSG), are often associated with severe side effects...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Di Mascolo, Daniele, Lyon, Christopher, Aryal, Santosh, Ramirez, Maricela R., Wang, Jun, Candeloro, Patrizio, Guindani, Michele, Hsueh, Willa A., Decuzzi, Paolo
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4076002/
https://ncbi.nlm.nih.gov/pubmed/23791978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.06.012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker